One of the problems encountered with direct immunofluorescence, as with culture, is the need for proper specimen collection and the ability to obtain endocervical cells for analysis.3 Phillips and colleagues found that the number of cells present on the slide affected the direct immunofluorescence test results, and improved sensitivity was found when more endocervical cells were present.4 A swab is generally used to collect cervical material for analysis with direct immunofluorescence. Another device, the cervical Cytobrush (International Cytobrush, Hollywood, Florida, USA), has been used successfully at this school of medicine for performing Papanicolau smears and has also been found by Ros et al to be superior to swab collection of hndocervical cells for cytopathological analysis.5 Because of its abrasive surface, the Cytobrush might also be better at disrupting the infected cells present in cervical secretions and thus improve chlamydial detection. As part of studies ofchlamydial infections in our family planning clinic,2 we studied the use of the Cytobrush as a collection device for diagnosing chlamydial infection, and we compared it with swab collection.
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Patients and methods
We studied women aged 15 to 19 who attended the family planning clinic of the hospital of the University of Pennsylvania for routine gynaecological examination. In the first phase of the study, samples for chlamydial detection were collected using the MicroTrak collection device (MicroTrak, Syva Company, Palo Alto, California). This collection kit contains a glass slide for smear preparation, a dacron swab for sample collection, and fixative. In the second phase of the study, a Cytobrush (International Cytobrush, catalogue No 166100) was substituted for the dacron swab. The Cytobrush has a plastic shaft with nylon bristles arranged in a spiral at one end. In both phases, we collected endocervical cells in an identical fashion.
Statistical analysis of data was performed using Yate's corrected x2 analysis.
Results
In phase one of this study, of 103 consecutive samples taken using the MicroTrak swab as the collection device, 73 (71%) contained sufficient endocervical material for analysis. In phase two 88 (63%) of 139 patients sampled with the Cytobrush yielded adequate samples for analysis. The difference between the sampling efficiency of each group was not significant (X'c = 1197;p <0.3).
The table summarises the results of direct immunofluorescent of the adequate samples from both phases of the study. In phase one the percentage of positive samples was 12% compared with 27% in 245 phase two. The difference in detection in the two phases was significant (X2c = 4-61; p < 005).
Discussion
We found that the use of the Cytobrush more than doubled the detection of chlamydiae. This increase, however, did not appear to be caused by an overall improvement in sample adequacy, as the proportions of negative results in both phases of the study were similar (88% in phase one, 73% in phase two). Sampling with the brush was possibly better, though we did not count the number of endocervical cells present on the slides to make this comparison. The Cytobrush is more abrasive than a dacron swab and may have caused greater disruption of infected cells, thus improving positivity. Although this was not a randomised study and the number of patients studied was relatively small, we do not believe that the different positivity in the two phases can be attributed to differences in the population or to a spontaneous increase in chlamydial infection. Both groups of patients were of the same socioeconomic class and age as those routinely seen for gynaecological examination. During the same period as the study, the overall clinic incidence of Ciotti, Sondheimer, Nachamkin gonococcal infection was similar (4% in both phases).
In addition, the incidence of gonococcal infection was similar (6%) in each group of patients.
Although the brush appeared to improve chlamydial detection, we did encounter problems with its use. In general, we rejected more samples obtained with the Cytobrush than with the swab because of the presence of gross blood. In addition, cervical bleeding was more a problem with the brush than with the swab device. On occasion, however, positive samples may be detected in the presence of gross blood. Under this circumstance, the results should be reported as being positive and are acceptable for evaluation.
Our findings suggest that additional randomised studies should be performed to assess the usefulness of the Cytobrush in improving the diagnosis of chlamydial infection. AIDS were positive for antibodies to HIV-I compared with only 1/27 wives of seronegative controls.2 Another study undertaken in Kinshasa showed that of 3000 couples tested, in 80 cases the male partner was infected, and in only 20/80 (25%) cases were both spouses infected. 3 The high rate of infectivity in the first Zairian study was probably because all the men had AIDS, whereas in the second study, as well as in ours, the subjects were clinically healthy. ' The incidence of heterosexual transmission that we report in the present survey is higher than in wives of men infected through blood products. Several hypotheses may explain this finding. In Africa, chronic stimulation of the immune system is more common than in American heterosexuals, thus possibly increasing the number oftarget cells that the virus can infect. The 8th meeting of the ISSTDR will be held on 10-13 September 1989 in Copenhagen, Denmark.
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